Regulation of aortic extracellular matrix synthesis via noradrenergic system and angiotensin II in juvenile rats

References

• Aberdeen J, Corr L, Milner P, Lincoln J, Burnstock G. (1990). Marked increases in calcitonin gene-related peptide-containing nerves in the developing rat following long-term sympathectomy with guanethidine. Neuroscience, 35, 175–184.
   PubMed Web of Science ®Google Scholar
• Aliev G, Ralevic V, Burnstock G. (1996). Depression of endothelial nitric oxide synthase but increased expression of endothelin-1 immunoreactivity in rat thoracic aortic endothelium associated with long-term, but not short-term, sympathectomy. Circ Res, 79, 317–323.
   PubMed Web of Science ®Google Scholar
• Balakrishnan SM, Wang HD, Gopalakrishnan V, Wilson TW, McNeill JR. (1996). Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension, 28, 806–809.
   PubMedGoogle Scholar
• Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA. (2001). Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J Cardiovasc Pharmacol, 38, 141–148.
   PubMedGoogle Scholar
• Benetos A, Lacolley P, Safar ME. (1997). Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol, 17, 1152–1156.
   PubMed Web of Science ®Google Scholar
• Chan YC, Leung PS. (2007). Angiotensin II type 1 receptor-dependent nuclear factor-κB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis. J Pharmacol Exp Ther, 323, 10–18.
   PubMedGoogle Scholar
• Chavez JC, LaManna JC. (2002). Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: Potential role of insulin-like growth factor-1. J Neurosci, 22, 8922–8931.
   PubMed Web of Science ®Google Scholar
• Cox SL, Ben A, Story DF, Ziogas J. (1995). Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites. Br J Pharmacol, 114, 1057–1063.
   PubMedGoogle Scholar
• Dab H, Hachani R, Hodroj W, Sakly M, Bricca G, Kacem K. (2009a). Differential control of MMP and t-PA/PAI-1 expressions by sympathetic and renin-angiotensin systems in rat left ventricle. Auton Neurosci, 150, 27–32.
   PubMed Web of Science ®Google Scholar
• Dab H, Hachani R, Hodroj W, Sakly M, Bricca G, Kacem K. (2009b). Differential control of collagen synthesis by the sympathetic and renin-angiotensin systems in the rat left ventricle. Auton Neurosci, 151, 106–110.
   PubMedGoogle Scholar
• Dab H, Hachani R, Hodroj W, Sakly M, Bricca G, Kacem K. (2011b). Interaction between sympathetic nervous system and renin angiotensin system on MMPs expression in juvenile rat aorta. Gen Physiol Biophys, 30, 271–277.
   PubMedGoogle Scholar
• Dab H, Hachani R, Dhaouadi N, Hodroj W, Sakly M, Randon J, Bricca G, Kacem K. (2011a). Physiological regulation of MMPs and tPA/PAI in the arterial wall of rats by noradrenergic tone and angiotensin II. J Renin Angiotensin Aldosterone Syst. DOI: 10.1177/1470320311414752.
   Google Scholar
• Dao HH, Lemay J, de Champlain J, deBlois D, Moreau P. (2001). Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent. J Hypertens, 19, 1965–1973.
   PubMedGoogle Scholar
• Dendorfer A, Raasch W, Tempel K, Dominiak P. (1998). Interactions between the renin-angiotensin system (RAS) and the sympathetic system. Basic Res Cardiol, 93 Suppl 2, 24–29.
   PubMedGoogle Scholar
• d’Uscio LV, Shaw S, Barton M, Lüscher TF. (1998). Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: Role of blood pressure and endothelial function. Hypertension, 31, 1305–1310.
   PubMed Web of Science ®Google Scholar
• Dwyer KW, Provenzano PP, Muir P, Valhmu WB, Vanderby R Jr. (2004). Blockade of the sympathetic nervous system degrades ligament in a rat MCL model. J Appl Physiol, 96, 711–718.
   PubMed Web of Science ®Google Scholar
• Facoetti A, Fallarini S, Miserere S, Bertolotti A, Ferrero I, Tozzi R, Gatti C, Palladini G, Perlini S, Nano R. (2006). Histochemical study of cardiac mast cells degranulation and collagen deposition: Interaction with the cathecolaminergic system in the rat. Eur J Histochem, 50, 133–140.
   PubMedGoogle Scholar
• Fondard O, Detaint D, Iung B, Choqueux C, Adle-Biassette H, Jarraya M, Hvass U, Couetil JP, Henin D, Michel JB, Vahanian A, Jacob MP. (2005). Extracellular matrix remodelling in human aortic valve disease: The role of matrix metalloproteinases and their tissue inhibitors. Eur Heart J, 26, 1333–1341.
   PubMed Web of Science ®Google Scholar
• Ford CM, Li S, Pickering JG. (1999). Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-β, and tyrosine phosphorylation. Arterioscler Thromb Vasc Biol, 19, 1843–1851.
   PubMedGoogle Scholar
• Fronek K, Bloor CM, Amiel D, Chvapil M. (1978). Effect of long-term sympathectomy on the arterial wall in rabbits and rats. Exp Mol Pathol, 28, 279–289.
   PubMed Web of Science ®Google Scholar
• Gironacci MM, Adler-Graschinsky E, Peña C, Enero MA. (1994). Effects of angiotensin II and angiotensin-(1-7) on the release of [3H] norepinephrine from rat atria. Hypertension, 24, 457–460.
   PubMedGoogle Scholar
• Hilgers KF, Veelken R, Rupprecht G, Reeh PW, Luft FC, Mann JF. (1993). Angiotensin II facilitates sympathetic transmission in rat hind limb circulation. Hypertension, 21, 322–328.
   PubMedGoogle Scholar
• Iwatsuki K, Cardinale GJ, Spector S, Udenfriend S. (1979). Effect of guanethidine on collagen biosynthesis in blood vessels of hypertensive rats. Arch Int Pharmacodyn Ther, 240, 278–284.
   PubMedGoogle Scholar
• Izzo JL Jr. (2000). Systolic hypertension, arterial stiffness, and vascular damage: Role of the renin-angiotensin system. Blood Press Monit, 5 Suppl 2, S7–11.
   Google Scholar
• Izzo JL Jr, Shykoff BE. (2001). Arterial stiffness: Clinical relevance, measurement, and treatment. Rev Cardiovasc Med, 2, 29–34, 37.
   PubMedGoogle Scholar
• Jacob MP. (2003). Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother, 57, 195–202.
   PubMed Web of Science ®Google Scholar
• Johnson BM. (1975). The use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK & F 24260 on the redistribution of cardiac output in anaesthetized rabbits. Br J Pharmacol, 55, 393–402.
   PubMedGoogle Scholar
• Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. (1991). Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens, 9, 17–22.
   PubMed Web of Science ®Google Scholar
• Kizer JR, Dahlöf B, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Wachtell K, Edelman JM, Snapinn SM, Harris KE, Devereux RB. (2005). Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: The Losartan Intervention For Endpoint reduction in hypertension study. Hypertension, 45, 46–52.
   PubMed Web of Science ®Google Scholar
• Kopecky SL. (2006). Effect of β blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction. Am J Cardiol, 98, 1115–1119.
   PubMedGoogle Scholar
• Lee MA, Böhm M, Paul M, Ganten D. (1993). Tissue renin-angiotensin systems. Their role in cardiovascular disease. Circulation, 87, IV7–I13.
   PubMedGoogle Scholar
• Lurie KG, Bristow MR, Minobe WA, Masek M, Billingham ME. (1988). 6-Hydroxydopamine mediated cardiotoxicity in rabbits. Am J Cardiovasc Pathol, 2, 181–191.
   PubMedGoogle Scholar
• O’Callaghan CJ, Williams B. (2002). The regulation of human vascular smooth muscle extracellular matrix protein production by α- and β-adrenoceptor stimulation. J Hypertens, 20, 287–294.
   PubMedGoogle Scholar
• Ralevic V, Milner P, Burnstock G. (1995). Augmented flow-induced endothelin release from the rat mesenteric arterial bed after long-term sympathectomy. Endothelium 3, 67–73.
   Google Scholar
• Rizvi MA, Katwa L, Spadone DP, Myers PR. (1996). The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Cardiol, 28, 243–252.
   PubMed Web of Science ®Google Scholar
• Rocha FL, Carmo EC, Roque FR, Hashimoto NY, Rossoni LV, Frimm C, Anéas I, Negrão CE, Krieger JE, Oliveira EM. (2007). Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats. Am J Physiol Heart Circ Physiol, 293, H3575–H3583.
   PubMed Web of Science ®Google Scholar
• Senzaki H, Paolocci N, Gluzband YA, Lindsey ML, Janicki JS, Crow MT, Kass DA. (2000). β-Blockade prevents sustained metalloproteinase activation and diastolic stiffening induced by angiotensin II combined with evolving cardiac dysfunction. Circ Res, 86, 807–815.
   PubMed Web of Science ®Google Scholar
• Simon G, Csiky B. (1998). Effect of neonatal sympathectomy on the development of structural vascular changes in angiotensin II-treated rats. J Hypertens, 16, 77–84.
   PubMedGoogle Scholar
• Spinetti G, Kraenkel N, Emanueli C, Madeddu P. (2008). Diabetes and vessel wall remodelling: From mechanistic insights to regenerative therapies. Cardiovasc Res, 78, 265–273.
   PubMed Web of Science ®Google Scholar
• Tokimitsu I, Kato H, Wachi H, Tajima S. (1994). Elastin synthesis is inhibited by angiotensin II but not by platelet-derived growth factor in arterial smooth muscle cells. Biochim Biophys Acta, 1207, 68–73.
   PubMedGoogle Scholar
• Velleman SG, McCormick RJ, Ely D, Jarrold BB, Patterson RA, Scott CB, Daneshvar H, Bacon WL. (2001). Collagen characteristics and organization during the progression of cholesterol-induced atherosclerosis in Japanese quail. Exp Biol Med (Maywood), 226, 328–333.
   PubMedGoogle Scholar
• Villanueva I, Piñón M, Quevedo-Corona L, Martínez-Olivares R, Racotta R. (2003). Epinephrine and dopamine colocalization with norepinephrine in various peripheral tissues: Guanethidine effects. Life Sci, 73, 1645–1653.
   PubMedGoogle Scholar
• Wang M, Zhang J, Spinetti G, Jiang LQ, Monticone R, Zhao D, Cheng L, Krawczyk M, Talan M, Pintus G, Lakatta EG. (2005). Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am J Pathol, 167, 1429–1442.
   PubMed Web of Science ®Google Scholar
• Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, Yusuf S, Böhm M. (2008). RAS blockade with ARB and ACE inhibitors: Current perspective on rationale and patient selection. Clin Res Cardiol, 97, 418–431.
   PubMed Web of Science ®Google Scholar
• Zucker IH, Wang W, Pliquett RU, Liu JL, Patel KP. (2001). The regulation of sympathetic outflow in heart failure. The roles of angiotensin II, nitric oxide, and exercise training. Ann N Y Acad Sci, 940, 431–443.
   PubMed Web of Science ®Google Scholar